Related Experiment Video
Updated: Jun 16, 2025

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Phosphatase-independent activity of smooth-muscle calcineurin orchestrates a gene expression program leading to
Paula Sofía Yunes-Leites1,2, Yilin Sun2,3, Sara Martínez-Martínez1,2
1Gene Regulation in Cardiovascular Remodeling and Inflammation Group, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Abstract:
Angiotensin-II (Ang-II) drives pathological vascular wall remodeling in hypertension and abdominal aortic aneurysm (AAA) through mechanisms that are not completely understood. Previous studies showed that the phosphatase activity of calcineurin (Cn) mediates Ang-II-induced AAA, but the cell type involved in the action of Cn in AAA formation remained unknown. Here, by employing newly created smooth muscle cell (SMC)-specific and endothelial cell (EC)-specific Cn-deficient mice (SM-Cn-/- and EC-Cn-/- mice), we show that Cn expressed in SMCs, but not ECs, was required for Ang-II-induced AAA. Unexpectedly, SMC Cn also played a structural role in the early onset and maintenance of Ang-II-induced hypertension, independently of its known phosphatase activity. Among the signaling pathways activated by Ang-II, Cn signaling is essential in SMCs, as nearly 90% of the genes regulated by Ang-II in the aorta required Cn expression in SMCs. Cn orchestrated, independently of its enzymatic activity, the induction by Ang-II of a transcriptional program closely related to SMC contractility and hypertension. Cn deletion in SMCs, but not its pharmacological inhibition, impaired the regulation of arterial contractility. Among the genes whose regulation by Ang-II required Cn expression but not its phosphatase activity, we discovered that Serpine1 was critical for Ang-II-induced hypertension. Indeed, pharmacological inhibition of PAI-1, the protein encoded by Serpine1, impaired SMCs contractility and readily regressed hypertension. Mechanistically, Serpine1 induction was mediated by Smad2 activation via the structural role of Cn. These findings uncover an unexpected role for Cn in vascular pathophysiology and highlight PAI-1 as a potential therapeutic target for hypertension.
Insights
Calcineurin (Cn) in smooth muscle cells (SMCs) drives Angiotensin-II (Ang-II) induced hypertension and abdominal aortic aneurysm (AAA). This structural role of SMC calcineurin, independent of phosphatase activity, highlights PAI-1 as a potential therapeutic target for hypertension.
Area of Science:
- Vascular Biology
- Cardiovascular Physiology
- Molecular Medicine
Background:
- Angiotensin-II (Ang-II) promotes vascular remodeling in hypertension and abdominal aortic aneurysm (AAA).
- Calcineurin (Cn) phosphatase activity mediates Ang-II-induced AAA, but the specific cell type involved was unknown.
- Understanding the precise role of Cn in Ang-II-driven vascular pathologies is crucial.
Purpose of the Study:
- To determine the cell-specific role of calcineurin (Cn) in Angiotensin-II (Ang-II) induced abdominal aortic aneurysm (AAA) and hypertension.
- To investigate the mechanisms underlying Cn's function in vascular pathophysiology.
- To identify novel therapeutic targets for Ang-II-mediated cardiovascular diseases.
Main Methods:
- Generation of smooth muscle cell (SMC)-specific and endothelial cell (EC)-specific Cn-deficient mice (SM-Cn-/- and EC-Cn-/-).
- Administration of Ang-II to induce hypertension and AAA in genetically modified mice.
- Analysis of gene expression, protein activity, and vascular contractility.
- Pharmacological inhibition of PAI-1 (Serpine1 protein).
Main Results:
- Cn in SMCs, not ECs, is essential for Ang-II-induced AAA.
- SMC Cn plays a structural role in Ang-II-induced hypertension, independent of its phosphatase activity.
- Cn signaling in SMCs regulates ~90% of Ang-II-responsive genes in the aorta, impacting SMC contractility.
- Serpine1 induction by Ang-II, mediated by Smad2 and structural Cn, is critical for hypertension; PAI-1 inhibition regresses hypertension.
Conclusions:
- Calcineurin in smooth muscle cells is a key mediator of Ang-II-induced vascular pathologies, including AAA and hypertension.
- Cn's structural, non-enzymatic role in regulating SMC contractility and gene expression is critical.
- PAI-1 emerges as a significant downstream effector and a potential therapeutic target for hypertension.
More Related Videos
08:08Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta
Published on: June 10, 2015
07:51Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography
Published on: September 22, 2011
Related Concept Videos
Nitric Oxide Signaling Pathway
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Antihypertensive Drugs: Action of Calcium Channel Blockers
Smooth Muscle Contraction
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
Amplifying Signals via Enzymatic Cascade
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include: